Carbamazepine

Clinical Indication

Epilepsy

Comments

MHRA alert (Dec 2014) adverse effects on bone and MHRA alert (Nov 2017) updated advice on switching between different manufacturers’ products

Date of classification

August 2024

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .